Elspar and coagulopathy 
Elspar and coagulopathy Patient Reports February 12, 2012
Elspar Side Effects Report #5097771-0
Elspar side effect was reported by a Health Professional from SPAIN on Aug 18, 2006. Male patient, 16 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Elspar. After drug was administered, patient experienced the following side effects: cerebral haematoma, coagulopathy, constipation
, myelopathy, urinary incontinence . Elspar dosage: unknown. During the same period patient was treated with DAUNORUBICIN, VINCRISTINE, PREDNISONE, CYCLOPHOSPHAMIDE, METHOTREXATE, CYTARABINE, HYDROCORTISONE, MERCAPTOPURINE. Patient recovered.Elspar Side Effects Report #5114563-4
Elspar side effect was reported by a Health Professional from SPAIN on Sept 08, 2006. Male patient, 16 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Elspar. After drug was administered, patient experienced the following side effects: cerebral haematoma, coagulopathy, constipation
, hemiparesis, myelopathy, neutropenia, paraplegia, urinary incontinence . Elspar dosage: unknown. During the same period patient was treated with DAUNORUBICIN, VINCRISTINE, PREDNISONE, CYCLOPHOSPHAMIDE, METHOTREXATE, CYTARABINE, HYDROCORTISONE, MERCAPTOPURINE. Patient recovered.Elspar Side Effects Report #4562557-X
Elspar side effect was reported by a Health Professional from on Jan 14, 2005. Female patient, 13 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Elspar. After drug was administered, patient experienced the following side effects: antithrombin iii decreased, blood fibrinogen decreased, cerebral thrombosis, coagulopathy, plasminogen decreased. Elspar dosage: unknown. Patient was hospitalized. Patient recovered.
Elspar Side Effects Report #4583204-7
Elspar side effect was reported by a Health Professional from on Jan 14, 2005. Female patient, 13 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Elspar. After drug was administered, patient experienced the following side effects: antithrombin iii decreased, blood fibrinogen decreased, cerebral thrombosis, coagulopathy, plasminogen decreased. Elspar dosage: unknown. Patient was hospitalized. Patient recovered.
Elspar Side Effects Report #5603400-7
Elspar side effect was reported by a Consumer or non-health professional from ITALY on Jan 08, 2008. Male patient, child 10 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Elspar. After drug was administered, patient experienced the following side effects: blood cholesterol increased, coagulopathy, hypertriglyceridaemia, pancreatitis, plasmapheresis. Elspar dosage: unknown. During the same period patient was treated with PREDNISONE, VINCRISTINE, DAUNORUBICIN, METHOTREXATE. Patient recovered.